Remdesivir manufacturer claims reduced deaths of coronavirus patients

The manufacturer of antiviral drug remdesivir, Gilead Sciences claimed on Friday that late-stage study showed a reduced the risk of death and also significantly improved the conditions of severely ill coronavirus patients. The company added that the finding requires confirmation in clinical trials. Remdesivir has been at the forefront of the battle against COVID-19 after […]